Details for New Drug Application (NDA): 208824
✉ Email this page to a colleague
The generic ingredient in TADALAFIL is tadalafil. There are twenty-five drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the tadalafil profile page.
Summary for 208824
Tradename: | TADALAFIL |
Applicant: | Hangzhou Binjiang |
Ingredient: | tadalafil |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 208824
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 2.5MG | ||||
Approval Date: | Oct 27, 2020 | TE: | AB1 | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
Approval Date: | Oct 27, 2020 | TE: | AB1 | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
Approval Date: | Oct 27, 2020 | TE: | AB1 | RLD: | No |
Complete Access Available with Subscription